loadpatents
name:-0.048705101013184
name:-0.02498984336853
name:-0.0094351768493652
Lehmann; Juerg Patent Filings

Lehmann; Juerg

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lehmann; Juerg.The latest application filed is for "modulators of the gpr119 receptor and the treatment of disorders related thereto".

Company Profile
9.25.41
  • Lehmann; Juerg - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
5-HT.sub.2C receptor agonists and compositions and methods of use
Grant 11,395,824 - Lehmann , et al. July 26, 2
2022-07-26
Modulators Of The Gpr119 Receptor And The Treatment Of Disorders Related Thereto
App 20210340133 - Jones; Robert M. ;   et al.
2021-11-04
Modulators of the GPR119 receptor and the treatment of disorders related thereto
Grant 10,894,787 - Jones , et al. January 19, 2
2021-01-19
SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
App 20200407316 - Jones; Robert M. ;   et al.
2020-12-31
5-ht2c Receptor Agonists And Compositions And Methods Of Use
App 20200383993 - Lehmann; Juerg ;   et al.
2020-12-10
3-phenyl-pyrazole derivatives as modulators of the 5-HT.sub.2A serotonin receptor useful for the treatment of disorders related thereto
Grant 10,781,180 - Teegarden , et al. Sept
2020-09-22
5-HT.sub.2C receptor agonists and compositions and methods of use
Grant 10,624,900 - Lehmann , et al.
2020-04-21
5-ht2c Receptor Agonists And Compositions And Methods Of Use
App 20200078368 - Lehmann; Juerg ;   et al.
2020-03-12
3-phenyl-pyrazole Derivatives As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Treatment Of Disorders Related There
App 20190263757 - Teegarden; Bradley ;   et al.
2019-08-29
SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
App 20190135752 - Jones; Robert M. ;   et al.
2019-05-09
5-HT2C receptor agonists and compositions and methods of use
Grant 10,272,094 - Lehmann , et al.
2019-04-30
5-ht2c Receptor Agonists And Compositions And Methods Of Use
App 20180214455 - Lehmann; Juerg ;   et al.
2018-08-02
SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
App 20170217885 - Jones; Robert M. ;   et al.
2017-08-03
1-heteroaryl-indoline-4-carboxamides as modulators of GPR52 useful for the treatment or prevention of disorders related thereto
Grant 9,676,758 - Xiong , et al. June 13, 2
2017-06-13
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
Grant 9,522,133 - Jones , et al. December 20, 2
2016-12-20
1-heteroaryl-indoline-4-carboxamides As Modulators Of Gpr52 Useful For The Treatment Or Prevention Of Disorders Related Thereto
App 20160318911 - Xiong; Yifeng ;   et al.
2016-11-03
3-phenyl-pyrazole Derivatives As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto
App 20160304463 - Teegarden; Bradley ;   et al.
2016-10-20
Substituted Tricyclic Acid Derivatives As S1p1 Receptor Agonists Useful In The Treatment Of Autoimmune And Inflammatory Disorders
App 20150336966 - Jones; Robert M. ;   et al.
2015-11-26
SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
App 20150335618 - Jones; Robert M. ;   et al.
2015-11-26
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
Grant 9,126,932 - Jones , et al. September 8, 2
2015-09-08
Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
Grant 9,108,969 - Jones , et al. August 18, 2
2015-08-18
3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
Grant 8,785,441 - Teegarden , et al. July 22, 2
2014-07-22
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
App 20140066369 - Jones; Robert M. ;   et al.
2014-03-06
Modulators Of The Gpr119 Receptor And The Treatment Of Disorders Related Thereto
App 20140051629 - Jones; Robert M. ;   et al.
2014-02-20
SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
App 20140038987 - Jones; Robert M. ;   et al.
2014-02-06
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
App 20140018371 - Jones; Robert M. ;   et al.
2014-01-16
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
Grant 8,580,841 - Jones , et al. November 12, 2
2013-11-12
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
Grant 8,546,429 - Jones , et al. October 1, 2
2013-10-01
3-phenyl-pyrazole Derivatives As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto
App 20130237540 - TEEGARDEN; BRADLEY ;   et al.
2013-09-12
Substituted Tricyclic Acid Derivatives As S1p1 Receptor Agonists Useful In The Treatment Of Autoimmune And Inflammatory Disorders
App 20130184307 - Jones; Robert M. ;   et al.
2013-07-18
Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
Grant 8,415,484 - Jones , et al. April 9, 2
2013-04-09
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
Grant 8,362,248 - Jones , et al. January 29, 2
2013-01-29
Modulators Of The Gpr119 Receptor And The Treatment Of Disorders Related Thereto
App 20130023494 - Jones; Robert M. ;   et al.
2013-01-24
GPR119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto
Grant 8,101,626 - Chu , et al. January 24, 2
2012-01-24
Substituted Tricyclic Acid Derivatives As S1p1 Receptor Agonists Useful In The Treatment Of Autoimmune And Inflammatory Disorders
App 20110160243 - Jones; Robert M. ;   et al.
2011-06-30
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic Acid Derivatives Useful In The Treatment Of Autoimmune And Inflammatory Disorders
App 20110130409 - Jones; Robert M. ;   et al.
2011-06-02
1,2,3-trisubstituted Aryl And Heteroaryl Derivatives As Modulators Of Metabolism And The Prophylaxis And Treatment Of Disorders Related Thereto
App 20110112060 - Jones; Robert M. ;   et al.
2011-05-12
3-phenyl-pyrazole Derivatives As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto
App 20110105456 - Teegarden; Bradley ;   et al.
2011-05-05
3-phenyl-pyrazole derivatives as modulators of the 5-HT.sub.2A serotonin receptor useful for the treatment of disorders related thereto
Grant 7,884,101 - Teegarden , et al. February 8, 2
2011-02-08
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
Grant 7,838,525 - Jones , et al. November 23, 2
2010-11-23
GRP119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto
Grant 7,816,364 - Chu , et al. October 19, 2
2010-10-19
GPR119 Receptor Agonists in Methods of Increasing Bone Mass and of Treating Osteoporosis and Other Conditions Characterized by Low Bone Mass, and Combination Therapy Relating Thereto
App 20100190750 - Chu; Zhi-Liang ;   et al.
2010-07-29
Modulators of Metabolism and the Treatment of Disorders Related Thereto
App 20100160359 - Jones; Robert M. ;   et al.
2010-06-24
Modulators of metabolism and the treatment of disorders related thereto
App 20100004272 - Jones; Robert M. ;   et al.
2010-01-07
Modulators Of Metabolism And The Treatment Of Disorders Related Thereto
App 20090286816 - Jones; Robert M. ;   et al.
2009-11-19
GPR119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto
App 20090270422 - Chu; Zhi-Liang ;   et al.
2009-10-29
Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
App 20090036434 - Jones; Robert M. ;   et al.
2009-02-05
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
Grant 7,470,699 - Jones , et al. December 30, 2
2008-12-30
3-Phenyl-Pyrazole Derivatives as Modulators of the 5-Ht2A Serotonin Receptor Useful for the Treatment of Disorders Related Thereto
App 20070244086 - Teegarden; Bradley ;   et al.
2007-10-18
3-Phenyl-pyrazole derivatives as modulators of the 5-HT2a serotonin receptor useful for the treatment of disorders related thereto
App 20070207994 - Teegarden; Bradley ;   et al.
2007-09-06
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
App 20070167473 - Jones; Robert M. ;   et al.
2007-07-19
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the phophylaxis and treatment of disorders related thereto
App 20070155763 - Jones; Robert M. ;   et al.
2007-07-05
Substituted pyrindinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
App 20070078150 - Jones; Robert M. ;   et al.
2007-04-05
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
App 20060155128 - Jones; Robert M. ;   et al.
2006-07-13
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
App 20050070562 - Jones, Robert M. ;   et al.
2005-03-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed